GW0742 is a selective PPAR-delta agonist similar to Cardarine (GW501516) but with higher binding affinity and potentially greater effects.
GW0742 vs Cardarine
- 200x higher PPAR-delta binding affinity
- Enhanced fat oxidation
- Potentially better endurance effects
Research Benefits
- Increased endurance capacity
- Enhanced fat burning
- Improved lipid profile
- Anti-inflammatory effects
Dosing
10-20mg daily for 8-12 weeks.
Research compounds are NOT equivalent to FDA-approved pharmaceuticals.